Michael Mrochen

Michael Mrochen is a highly experienced professional in the field of medical optics and ophthalmology, currently serving as Co-Founder of Allotex since June 2016, where innovative tissue addition technology is developed to create living contact lenses. Alongside this role, Mrochen holds advisory positions with Swiss Vision Group and serves on the board of Pallas Kliniken. Additionally, Mrochen contributes expertise as a board member at SCHWIND eye-tech-solutions GmbH and as Chairman of the Board for Vivior AG. As a founder and CEO of IROC Science to Innovation and a former member of the Investment Committee at aescuvest, Mrochen showcases a strong entrepreneurial spirit within the investment sector. With a profound background as a renowned keynote speaker at numerous prestigious conferences since 1996, Mrochen also boasts a solid academic foundation with a habilitation from ETH Zürich and a doctorate in medical physics from Technische Universität Dresden.